Invasive Aspergillosis Withdrawn Phase 1 Trials for Pantoprazole (DB00213)

Also known as: Aspergillosis Invasive

IndicationStatusPhase
DBCOND0031838 (Invasive Aspergillosis)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03095547Drug/Drug Interactions With F901318Treatment